Oxford BioMedica plc Stock London S.E.
Equities
GB0006648157_GB
GB0006648157
Biotechnology & Medical Research
Sales 2023 | 89.54M 114M 156M | Sales 2024 * | 130M 165M 225M | Capitalization | 327M 416M 569M |
---|---|---|---|---|---|
Net income 2023 | -157M -200M -273M | Net income 2024 * | -37M -47.12M -64.39M | EV / Sales 2023 | 2.38 x |
Net cash position 2023 * | 49.23M 62.69M 85.67M | Net cash position 2024 * | 18.68M 23.79M 32.51M | EV / Sales 2024 * | 2.38 x |
P/E ratio 2023 |
-1.35
x | P/E ratio 2024 * |
-9.03
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.81% |
Latest transcript on Oxford BioMedica plc
Managers | Title | Age | Since |
---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 62 | 23-03-26 |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 17-08-28 |
Chairman | 68 | 20-06-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leone Patterson
BRD | Director/Board Member | 61 | 23-04-30 |
Chairman | 68 | 20-06-23 | |
Stuart Henderson
BRD | Director/Board Member | 66 | 16-05-31 |
1st Jan change | Capi. | |
---|---|---|
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |